Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
ALKS Coverage
Event
Alkermes plc (ALKS) Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2
Apr 1, 2026
Transcript
Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript
Mar 10, 2026
Event
Alkermes plc (ALKS) Forum
Mar 10, 2026
Event
Alkermes plc (ALKS) Sec Form 10K
Feb 26, 2026
Transcript
Alkermes plc (ALKS) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Alkermes plc (ALKS) Q3 2025 Earnings Call Transcript
Jan 22, 2026